Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation

globenewswire.com
A Agilent Technologies is mentioned as a prominent company in the global microfluidics market, indicating its involvement in this growing sector. The article does not provide specific positive or negative performance indicators for the company. TMO Thermo Fisher Scientific Inc. is listed as a prominent player in the microfluidics market. The article highlights the market's growth drivers, in which Thermo Fisher is likely participating, but offers no specific sentiment towards the company's performance. QGEN QIAGEN N.V. is identified as a key company in the microfluidics market. The article discusses the overall market growth and trends, suggesting QIAGEN's potential to benefit, but without specific details on the company's performance. ILMN Illumina, Inc. is mentioned as a prominent company in the microfluidics market. The article details the market's expansion and technological integration, implying Illumina's role, but without specific sentiment on its performance. LAB Standard BioTools Inc. is named as a prominent company in the microfluidics market. The article discusses the market's growth and technological advancements, implying Standard BioTools' participation, but without specific sentiment on its performance. DHR Danaher Corporation is identified as a prominent company in the microfluidics market. The article highlights market growth drivers such as diagnostics and drug development, areas where Danaher is likely active, but provides no specific sentiment. ABT Abbott is listed as a prominent company in the microfluidics market. The article discusses the growth in point-of-care diagnostics and clinical testing, areas relevant to Abbott, but offers no specific sentiment on the company's performance. BIO Bio-Rad Laboratories, Inc. is mentioned as a prominent company in the microfluidics market. The article details the market's growth drivers, including diagnostics and research, areas where Bio-Rad operates, but provides no specific sentiment.

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) -- "Microfluidics Market: Focus on Product Type, Application, End User, and Region - Analysis and Forecast, 2026-2036" has been added to ResearchAndMarkets.com's offering.

The global microfluidics market is projected to grow from $21.58 billion in 2025 to $48.04 billion by 2036, registering a CAGR of 7.49% during the forecast period 2026-2036. Market growth is being driven by rising demand for rapid and minimally invasive diagnostics, wider adoption of point-of-care testing, advances in genomic and single-cell analysis, and increased use of miniaturized, automated workflows in biomedical research and drug development.

Microfluidic technologies are increasingly integrated into molecular diagnostics, digital PCR, next-generation sequencing, cell-based assays, pharmaceutical formulation, organ-on-chip research, therapeutic delivery, and continuous or near-real-time monitoring. Commercial adoption is also supported by high-throughput platforms, recurring demand for proprietary consumables, improved automation, and integration with imaging, biosensors, artificial intelligence, and mass spectrometry.

Market Segmentation Highlights

By Product Type: Microfluidic consumables accounted for approximately 66.7% of the global market in 2025, making them the leading product segment. Demand is supported by recurring use of disposable chips, cartridges, plates, sequencing flow cells, diagnostic pouches and cards, integrated fluidic circuits, droplet-generation cartridges, and organ-on-chip plates. The segment is forecast to grow at a CAGR of 7.67% from 2026 to 2036, compared with 7.14% for microfluidic systems and platforms.

By Application: IVD and clinical testing held the largest market share in 2025 due to extensive use in molecular diagnostics, immunoassays, clinical chemistry, infectious disease testing, and point-of-care workflows. Therapeutic delivery and monitoring is expected to record the highest application CAGR of 9.50% through 2036, supported by controlled drug-delivery systems and wearable and implantable monitoring technologies.

By End User: Hospitals and diagnostic centers represented the largest end-user segment in 2025, reflecting strong demand for rapid testing, reduced sample requirements, and shorter turnaround times. Biopharmaceutical and biotechnology companies are forecast to achieve the highest CAGR of 8.53%, driven by applications in drug discovery, formulation development, screening, cell analysis, and single-cell research.

Regional Outlook: North America led the global microfluidics market in 2025, supported by its established biotechnology, pharmaceutical, diagnostics, and life science sectors. The U.S. remains the region's primary contributor because of substantial healthcare technology investment, advanced research infrastructure, and the presence of major platform and chip manufacturers.

Asia-Pacific is projected to register the highest regional CAGR of 8.72% from 2026 to 2036. Expansion across China, Japan, India, Singapore, Australia, and other regional markets is being supported by rising healthcare and life science R&D investment, growing biotechnology and pharmaceutical industries, and increasing demand for point-of-care diagnostics.

Market Drivers, Challenges, and Opportunities

Demand for rapid, minimally invasive, and patient-focused testing remains a central market driver. Microfluidic platforms can reduce sample and reagent requirements while integrating sample preparation, separation, reaction, and detection within compact workflows. Growing use of saliva, sweat, urine, and tears in diagnostic and monitoring applications is further expanding commercial opportunities.

Market development is constrained by limited standardization across chip materials, dimensions, fabrication methods, fluidic interfaces, connectors, assay protocols, and validation processes. Proprietary system architectures may restrict interoperability and complicate integration with laboratory infrastructure. Manufacturers must also address high capital requirements, regulatory differences, and challenges associated with scaling prototypes into reproducible commercial products.

Emerging markets offer significant growth potential as healthcare systems seek compact, portable, and scalable diagnostic solutions. Rising infectious and chronic disease testing needs, expanding pharmaceutical activity, and investment in decentralized healthcare are creating opportunities for affordable microfluidic systems and consumables. Companies with localized distribution, technical support, clinical validation, regulatory expertise, and scalable manufacturing capabilities are expected to gain a competitive advantage.

Recent Microfluidics Market Developments

Competitive Landscape

The global microfluidics market is technology-driven, with companies competing through platform throughput, automation, analytical sensitivity, precision, workflow integration, assay compatibility, scalable production, regulatory validation, and recurring consumable revenue. Product launches, platform upgrades, partnerships, acquisitions, and application-specific development remain important competitive strategies.

Prominent companies include Agilent Technologies, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Illumina, Inc., Revvity, Inc., Standard BioTools Inc., Merck KGaA, Randox Laboratories Ltd., microfluidic ChipShop GmbH, Fluidic Sciences, Danaher Corporation, Abbott, bioMerieux S.A., 10x Genomics, and Bio-Rad Laboratories, Inc.

Strategic Value of the Market Report

The report evaluates the microfluidics market by product type, application, end user, and region, enabling organizations to assess demand across systems, platforms, consumables, clinical testing, genomics, molecular biology, cell analysis, formulation, therapeutic delivery, and monitoring. Its findings can support product planning, market entry, partnership development, competitive positioning, and investment decisions.

Market estimates cover 2024 through 2036, with 2025 as the base year and 2026-2036 as the forecast period. The research combines company financial disclosures, product portfolio analysis, industry publications, regulatory filings, paid databases, and interviews with executives, product managers, laboratory directors, scientists, engineers, and technology specialists. Primary and secondary findings were used to validate market values, segment shares, regional performance, competitive trends, and emerging areas of innovation.

Key Topics Covered:

Executive Summary

Scope and Definition

1 Global Microfluidics Market: Industry Outlook

1.1 Market Overview and Ecosystem

1.1.1 Introduction

1.1.2 Characteristics of Market-Available Microfluidics Solutions

1.1.3 Microfluidics in Clinical Diagnostics

1.1.4 Global Footprint

1.2 Market Trends

1.2.1 Trends: Current and Future Impact Assessment

1.2.1.1 Impact Analysis

1.2.1.1.1 Increasing Commercialization of High-Throughput and Automated Microfluidic Platforms

1.3 Supply Chain Analysis

1.4 Market Dynamics

1.4.1 Market Drivers

1.4.1.1 Growing Demand for Non-Invasive and Rapid Diagnosis

1.4.1.2 Increase in Adoption of Personalized Medicine Shifting the Paradigm from Reaction to Prevention on a Global Level

1.4.1.3 Significant External Funding for Executing Research and Development Exercises

1.4.1.4 Growing Demand for Point-of-Care Diagnostics

1.4.2 Market Restraints

1.4.2.1 Lack of Standardization

1.4.2.2 Lack of High Complexity Testing Centers

1.4.2.3 High Capital Requirement Hampering the Expansion of Global Reach

1.4.3 Market Opportunities

1.4.3.1 Massive Scope for Adoption of Microfluidics-based Solutions in Emerging Nations

1.4.3.2 Increased Use of Microfluidics in Widespread Applications

1.4.3.3 Hybridization of Technologies

2 Global Microfluidics Market (by Product Type), $Million, 2024-2036

2.1 Market Sizing and Forecast

2.1.1 Microfluidic Systems and Platforms

2.1.2 Microfluidic Consumables

3 Global Microfluidics Market (by Application), $Billion, 2024-2036

3.1 Market Sizing and Forecast

3.1.1 IVD and Clinical Testing

3.1.2 Genomics and Molecular Biology

3.1.3 Cell Analysis and Cell-Based Assays

3.1.4 Microfluidic Formulation and Processing

3.1.5 Therapeutic Delivery and Monitoring

3.1.6 Other Applications

4 Global Microfluidics Market (by End User), $Billion, 2024-2036

4.1 Market Sizing and Forecast

4.1.1 Research and Academic Laboratories

4.1.2 Biopharmaceutical and Biotech Companies

4.1.3 Hospitals and Diagnostic Centers

4.1.4 Other End Users

5 Global Microfluidics Market (by Region), $Billion, 2024-2036

5.1 Regional Summary

5.2 Regional and Country Analysis

5.2.1 Coverage: Regional or Country Overview, Driving Factors for Market Growth, Factors Challenging the Market, Analyst View, and Market Sizing and Forecast

5.2.2 North America

5.2.2.1 U.S.

5.2.2.2 Canada

5.2.3 Europe

5.2.3.1 Germany

5.2.3.2 France

5.2.3.3 U.K.

5.2.3.4 Italy

5.2.3.5 Spain

5.2.3.6 Rest-of-Europe

5.2.4 Asia-Pacific

5.2.4.1 China

5.2.4.2 India

5.2.4.3 Japan

5.2.4.4 Singapore

5.2.4.5 Australia

5.2.4.6 Rest-of-Asia-Pacific

5.2.5 Latin America

5.2.5.1 Brazil

5.2.5.2 Mexico

5.2.5.3 Rest-of-Latin America

5.2.6 Rest-of-the-World

5.3 Industry Insights

5.3.1 Growth Share Analysis

5.3.2 Market Share Analysis

6 Competitive Benchmarking and Company Profiles

6.1 Key Strategies and Developments

6.2 Company Profiles

6.2.1 Standard Profile Coverage: Overview, Top Products, Role in the Global Microfluidics Market, Financials, Key Insights About Financial Health of the Company, and SWOT Analysis

6.2.2 Agilent Technologies, Inc.

6.2.3 Thermo Fisher Scientific Inc.

6.2.4 QIAGEN N.V.

6.2.5 Illumina, Inc.

6.2.6 Revvity, Inc.

6.2.7 Standard BioTools Inc.

6.2.8 Merck KGaA

6.2.9 Randox Laboratories Ltd.

6.2.9.1 Coverage: Overview, Top Products, Role in the Global Microfluidics Market, and SWOT Analysis

6.2.10 microfluidic ChipShop GmbH

6.2.10.1 Coverage: Overview, Top Products, Role in the Global Microfluidics Market, and SWOT Analysis

6.2.11 Fluidic Sciences

6.2.11.1 Coverage: Overview, Top Products, Role in the Global Microfluidics Market, and SWOT Analysis

6.2.12 Danaher Corporation

6.2.13 Abbott

6.2.14 bioMerieux S.A.

6.2.14.1 Additional Coverage: Analyst View

6.2.15 10x Genomics

6.2.16 Bio-Rad Laboratories, Inc.

7 Research Methodology

7.1 Data Sources

7.1.1 Primary Data Sources

7.1.2 Secondary Data Sources

7.1.3 Data Triangulation

7.2 Market Estimation and Forecast

List of Figures [48]

List of Tables [9]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/2goiq7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.